Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 1
2007 2
2019 3
2020 2
2021 2
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Circulating microvesicles across a population with various degree of cardiovascular burden are associated with systolic blood pressure.
Gavriilaki E, Lazaridis A, Anyfanti P, Yiannaki E, Dolgyras P, Nikolaidou B, Vasileiadis I, Alexandrou ME, Margouta A, Markala D, Zarifis I, Sarafidis P, Doumas M, Gkaliagkousi E. Gavriilaki E, et al. Among authors: yiannaki e. J Hum Hypertens. 2023 Dec;37(12):1105-1111. doi: 10.1038/s41371-023-00854-6. Epub 2023 Aug 23. J Hum Hypertens. 2023. PMID: 37612421 Review.
Assessment of microvesicles from different cell origins in patients with psoriasis: evidence of thrombogenic, proinflammatory microenvironment in the absence of established cardiovascular disease.
Margouta A, Anyfanti P, Lazaridis A, Gavriilaki E, Yiannaki E, Nikolaidou B, Goulas K, Lazaridou E, Triantafyllou A, Douma S, Patsatsi A, Gkaliagkousi E. Margouta A, et al. Among authors: yiannaki e. J Hum Hypertens. 2023 Oct;37(10):925-930. doi: 10.1038/s41371-022-00787-6. Epub 2022 Dec 8. J Hum Hypertens. 2023. PMID: 36482197
Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities.
Anyfanti P, Gavriilaki E, Nikolaidou B, Yiannaki E, Lazaridis A, Papadopoulos N, Douma S, Doumas M, Gkaliagkousi E. Anyfanti P, et al. Among authors: yiannaki e. J Thromb Thrombolysis. 2022 Jan;53(1):10-16. doi: 10.1007/s11239-021-02517-0. Epub 2021 Jul 5. J Thromb Thrombolysis. 2022. PMID: 34224067
Visceral Leishmaniasis in 2 Patients Treated With Lenalidomide and Dexamethasone: A Possible Correlation With Blunted Immune Response.
Hadjiaggelidou C, Vadikolia C, Verrou E, Yiannaki E, Triantafyllou T, Palaska V, Keramidioti K, Tsirou K, Papanikolaou A, Markala D, Konstantinidou P, Katodritou E. Hadjiaggelidou C, et al. Among authors: yiannaki e. Hemasphere. 2020 Dec 9;5(1):e506. doi: 10.1097/HS9.0000000000000506. eCollection 2021 Jan. Hemasphere. 2020. PMID: 33324952 Free PMC article. No abstract available.
Assessment of Endothelial Injury and Pro-Coagulant Activity Using Circulating Microvesicles in Survivors of Allogeneic Hematopoietic Cell Transplantation.
Gavriilaki E, Sakellari I, Anyfanti P, Batsis I, Vardi A, Bousiou Z, Lazaridis A, Nikolaidou B, Zarifis I, Masmanidou M, Yiannaki E, Markala D, Anagnostopoulos A, Douma S, Gkaliagkousi E. Gavriilaki E, et al. Among authors: yiannaki e. Int J Mol Sci. 2020 Dec 21;21(24):9768. doi: 10.3390/ijms21249768. Int J Mol Sci. 2020. PMID: 33371421 Free PMC article.
Evaluation of regulatory T cells (Tregs) alterations in patients with multiple myeloma treated with bortezomib or lenalidomide plus dexamethasone: correlations with treatment outcome.
Hadjiaggelidou C, Mandala E, Terpos E, Yiannaki E, Markala D, Triantafyllou T, Papatheodorou A, Gkastari V, Verrou E, Papanikolaou A, Konstantinidou P, Katodritou E. Hadjiaggelidou C, et al. Among authors: yiannaki e. Ann Hematol. 2019 Jun;98(6):1457-1466. doi: 10.1007/s00277-019-03657-3. Epub 2019 Mar 20. Ann Hematol. 2019. PMID: 30895351
13 results